Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals

Abstract Background Cortical deposition of β-amyloid (Aβ) plaque is one of the main hallmarks of Alzheimer’s disease (AD). While Aβ positivity has been the main concern so far, predicting whether Aβ (−) individuals will convert to Aβ (+) has become crucial in clinical and research aspects. In this s...

Full description

Bibliographic Details
Published in:	Alzheimer’s Research & Therapy
Main Authors:	Chae Jung Park, Younghoon Seo, Yeong Sim Choe, Hyemin Jang, Hyejoo Lee, Jun Pyo Kim, for the Alzheimer’s Disease Neuroimaging Initiative
Format:	Article
Language:	English
Published:	BMC 2022-09-01
Subjects:	Alzheimer’s disease Dementia Amyloid PET Prediction model Machine learning
Online Access:	https://doi.org/10.1186/s13195-022-01067-8

Similar Items

Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals
by: Elaheh Moradi, et al.
Published: (2024-02-01)

Self-Supervised Contrastive Learning to Predict the Progression of Alzheimer’s Disease with 3D Amyloid-PET
by: Min Gu Kwak, et al.
Published: (2023-09-01)

Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals
by: Motonobu Fujishima, et al.
Published: (2024-04-01)

Clinical effects of novel susceptibility genes for beta-amyloid: a gene-based association study in the Korean population
by: Bo-Hyun Kim, et al.
Published: (2023-10-01)

CSF Amyloid-β42 associates with neuropsychiatric and cognitive outcomes via cerebral glucose metabolism
by: Ali Azargoonjahromi, et al.
Published: (2025-07-01)

Plasma p‐tau217 concordance with amyloid PET among ethnically diverse older adults
by: Breton M. Asken, et al.
Published: (2024-07-01)

Whole-brain modeling of the differential influences of amyloid-beta and tau in Alzheimer’s disease
by: Gustavo Patow, et al.
Published: (2023-12-01)

Amyloid PET Radiopharmaceuticals and Imaging for Clinical and Research Applications in Thailand
by: Tossaporn Siriprapa, et al.
Published: (2023-09-01)

Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration
by: Keun You Kim, et al.
Published: (2024-09-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
by: Hákon Valur Dansson, et al.
Published: (2021-09-01)

Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration
by: Rory Boyle, et al.
Published: (2024-07-01)

Uptake of 18F-AV45 in the Putamen Provides Additional Insights into Alzheimer’s Disease beyond the Cortex
by: Zhengshi Yang, et al.
Published: (2024-01-01)

Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier
by: Dawn C. Matthews, et al.
Published: (2022-01-01)

Association between focal amyloid deposition and cognitive impairment in individuals below the amyloid threshold
by: Hongki Ham, et al.
Published: (2024-10-01)

Intracranial arteriosclerosis is not associated with cerebral amyloid deposition
by: Anna M. Streiber, et al.
Published: (2024-10-01)

Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-𝜷 in mild cognitive impairment but not in Alzheimer’s disease
by: Feng Xing, et al.
Published: (2021-06-01)

Language dysfunction correlates with cognitive impairments in older adults without dementia mediated by amyloid pathology
by: Chunchen Xiang, et al.
Published: (2023-05-01)

Comparison of Amyloid-PET Analysis Software Using <sup>18</sup>F-Florbetaben PET in Patients with Cognitive Impairment
by: Miju Cheon, et al.
Published: (2025-08-01)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
by: Poul F. Høilund-Carlsen, et al.
Published: (2023-07-01)

Reliability of Automated Amyloid PET Quantification: Real-World Validation of Commercial Tools Against Centiloid Project Method
by: Yeon-koo Kang, et al.
Published: (2025-07-01)

GAP-43 is associated with faster amyloid-associated neurodegeneration and cognitive decline in Alzheimer’s disease
by: Yaxin Li, et al.
Published: (2025-09-01)

Moderate‐ to high‐intensity exercise does not modify cortical β‐amyloid in Alzheimer's disease
by: Kristian S. Frederiksen, et al.
Published: (2019-01-01)

Accelerated hypometabolism with disease progression associated with faster cognitive decline among amyloid positive patients
by: Zhengshi Yang, et al.
Published: (2023-04-01)

Estimation of brain amyloid accumulation using deep learning in clinical [11C]PiB PET imaging
by: Claes Nøhr Ladefoged, et al.
Published: (2023-07-01)

Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease
by: Akihiro Kitani, et al.
Published: (2025-04-01)

Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease
by: Muhammad Ali, et al.
Published: (2023-04-01)

Discordant Amyloid Status Diagnosis in Alzheimer’s Disease
by: Lorena García-Vallés, et al.
Published: (2022-11-01)

Amyloid PET ordering practices in a memory disorders clinic
by: Katherine W. Turk, et al.
Published: (2022-01-01)

Metabolism as a biomarker for treatment success in anti-amyloid therapy: A case report
by: Kirk C. Wilhelmsen, et al.
Published: (2024-06-01)

Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change?
by: Gengsheng Chen, et al.
Published: (2024-01-01)

Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies
by: Ariane Bollack, et al.
Published: (2023-10-01)

Semiquantitative Approach to Amyloid Positron Emission Tomography Interpretation in Clinical Practice
by: Ana M. Franceschi, et al.
Published: (2022-10-01)

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
by: Shizuo Hatashita, et al.
Published: (2019-09-01)

Staging of amyloid β, t‐tau, regional atrophy rates, and cognitive change in a nondemented cohort: Results of serial mediation analyses
by: Evan Fletcher, et al.
Published: (2018-01-01)

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
by: Min Young Chun, et al.
Published: (2023-03-01)

Cerebrospinal fluid amyloid-β and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients
by: Qingze Zeng, et al.
Published: (2024-04-01)

The Cognivue Amyloid Risk Measure (CARM): A Novel Method to Predict the Presence of Amyloid with Cognivue Clarity
by: James E. Galvin, et al.
Published: (2025-04-01)

Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
by: Guanan Zhao, et al.
Published: (2024-01-01)

Independent effect of body mass index variation on amyloid-β positivity
by: Sung Hoon Kang, et al.
Published: (2022-07-01)

Translating amyloid PET of different radiotracers by a deep generative model for interchangeability
by: Seung Kwan Kang, et al.
Published: (2021-05-01)